Ergothioneine and TrkB Phosphorylation Dynamics in Psychedelic Therapy

Abstract

This project investigates the role of ergothioneine in modulating intracellular determinants of TrkB phosphorylation dynamics within the context of psychedelic-assisted therapy. Emerging evidence indicates that the durable therapeutic outcomes of psychedelics depend on brain-derived neurotrophic factor (BDNF) receptor TrkB signaling and downstream neuroplastic remodeling. However, clinical response variability suggests that baseline intracellular signaling capacity may constrain the magnitude and persistence of TrkB activation following psychedelic administration. This research framework proposes that intracellular redox balance, mitochondrial energetics, phosphatase activity, membrane microdomain integrity, and inflammatory tone collectively shape what may be described as TrkB phosphorylation readiness. Ergothioneine, a diet-derived amino-thione selectively transported via OCTN1 and enriched in stress-responsive cellular compartments, is hypothesized to influence these intracellular constraints and thereby modulate phosphorylation dynamics. The project currently includes a formal hypothesis manuscript outlining mechanistic pathways and testable predictions using extracellular vesicle-derived p-TrkB biomarkers. Future expansions may include protocol development, biomarker validation strategies, pilot study proposals, and interdisciplinary collaboration. This repository serves as a timestamped research record and platform for scholarly discussion of intracellular modulation of psychedelic-induced neuroplasticity.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

Keywords